{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:54Z","timestamp":1787020254284,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["5745"],"award-info":[{"award-number":["5745"]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["5745"],"award-info":[{"award-number":["5745"]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["5745"],"award-info":[{"award-number":["5745"]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56709-w","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:53:30Z","timestamp":1780757610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic evaluation of niosomal Rhoifolin in antileishmanial therapy and its additive potential with meglumine antimoniate"],"prefix":"10.1038","volume":"16","author":[{"given":"Raheleh Eftekhari","family":"Kenzerki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Karamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Pardakhty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Kheiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Salarkia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Keyhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"56709_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s42003-022-03240-z","volume":"5","author":"P Cec\u00edlio","year":"2022","unstructured":"Cec\u00edlio, P., Cordeiro-da-Silva, A. & Oliveira, F. Sand flies: basic information on the vectors of leishmaniasis and their interactions with Leishmania parasites. Commun. Biol. 5, 305 (2022).","journal-title":"Commun. Biol."},{"key":"56709_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fpubh.2020.00011","volume":"8","author":"MA Ghatee","year":"2020","unstructured":"Ghatee, M. A., Taylor, W. R. & Karamian, M. The geographical distribution of cutaneous leishmaniasis causative agents in Iran and its neighboring countries, a review. Front. Public. Health 8, 11 (2020).","journal-title":"Front. Public. Health"},{"key":"56709_CR3","doi-asserted-by":"crossref","unstructured":"Knight, C. A. et al. Leishmaniasis: Recent epidemiological studies in the Middle East. Front. Microbiol. 13, 1052478 (2023).","DOI":"10.3389\/fmicb.2022.1052478"},{"key":"56709_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.adengl.2021.05.011","volume":"112","author":"I Abad\u00edas-Granado","year":"2021","unstructured":"Abad\u00edas-Granado, I., Diago, A., Cerro, P., Palma-Ruiz, A. & Gilaberte, Y. Cutaneous and mucocutaneous leishmaniasis. Actas Dermo-Sifiliogr\u00e1ficas (English Edition). 112, 601\u2013618 (2021).","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"key":"56709_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.clindermatol.2019.10.008","volume":"38","author":"MS Gurel","year":"2020","unstructured":"Gurel, M. S., Tekin, B. & Uzun, S. Cutaneous leishmaniasis: a great imitator. Clin. Dermatol. 38, 140\u2013151 (2020).","journal-title":"Clin. Dermatol."},{"key":"56709_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jaad.2020.08.043","volume":"84","author":"CJ Scheufele","year":"2021","unstructured":"Scheufele, C. J., Giesey, R. L. & Delost, G. R. The global, regional, and national burden of leishmaniasis: an ecologic analysis from the Global Burden of Disease Study 1990\u20132017. J. Am. Acad. Dermatol. 84, 1203\u20131205 (2021).","journal-title":"J. Am. Acad. Dermatol."},{"key":"56709_CR7","unstructured":"Organization, W. H. Leishmaniasis (2025). https:\/\/www.who.int\/leishmaniasis\/en\/."},{"key":"56709_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1017\/S0031182022001640","volume":"150","author":"V Yurchenko","year":"2023","unstructured":"Yurchenko, V. et al. Revisiting epidemiology of leishmaniasis in central Asia: lessons learnt. Parasitology 150, 129\u2013136 (2023).","journal-title":"Parasitology"},{"key":"56709_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","volume":"23","author":"HJ de Vries","year":"2022","unstructured":"de Vries, H. J. & Schallig, H. D. Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. Am. J. Clin. Dermatol. 23, 823\u2013840 (2022).","journal-title":"Am. J. Clin. Dermatol."},{"key":"56709_CR10","unstructured":"Organization, W. H. The Global Epidemiology of Leishmaniasis (2024). https:\/\/www.who.int\/health-topics\/leishmaniasis\/the-global-epidemiology-of-leishmaniasis."},{"key":"56709_CR11","first-page":"143","volume":"15","author":"MR Razavi","year":"2021","unstructured":"Razavi, M. R. et al. Human cutaneous leishmaniosis in Iran, up to date-2019. J. Arthropod-Borne Dis. 15, 143 (2021).","journal-title":"J. Arthropod-Borne Dis."},{"key":"56709_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12982-024-00247-1","volume":"21","author":"WJ Mota","year":"2024","unstructured":"Mota, W. J. et al. Classical and innovative drugs for the treatment of Leishmania infections. Discover Public. Health. 21, 122 (2024).","journal-title":"Discover Public. Health"},{"key":"56709_CR13","doi-asserted-by":"publisher","first-page":"638957","DOI":"10.3389\/fmicb.2021.638957","volume":"12","author":"M Bamorovat","year":"2021","unstructured":"Bamorovat, M., Sharifi, I., Tavakoli Oliaee, R., Jafarzadeh, A. & Khosravi, A. Determinants of unresponsiveness to treatment in cutaneous leishmaniasis: a focus on anthroponotic form due to Leishmania tropica. Front. Microbiol. 12, 638957 (2021).","journal-title":"Front. Microbiol."},{"key":"56709_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.sajb.2019.01.008","volume":"129","author":"K Hammi","year":"2020","unstructured":"Hammi, K. et al. Antileishmanial activity of Moringa oleifera leaf extracts and potential synergy with amphotericin B. South. Afr. J. Bot. 129, 67\u201373 (2020).","journal-title":"South. Afr. J. Bot."},{"key":"56709_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bmc.2013.11.048","volume":"22","author":"N Singh","year":"2014","unstructured":"Singh, N., Mishra, B. B., Bajpai, S., Singh, R. K. & Tiwari, V. K. Natural product based leads to fight against leishmaniasis. Bioorg. Med. Chem. 22, 18\u201345 (2014).","journal-title":"Bioorg. Med. Chem."},{"key":"56709_CR16","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.phymed.2011.03.004","volume":"18","author":"R Sen","year":"2011","unstructured":"Sen, R. & Chatterjee, M. Plant derived therapeutics for the treatment of Leishmaniasis. Phytomedicine 18, 1056\u20131069 (2011).","journal-title":"Phytomedicine"},{"key":"56709_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2174\/092986710789957760","volume":"17","author":"G Leonarduzzi","year":"2010","unstructured":"Leonarduzzi, G., Testa, G., Sottero, B., Gamba, P. & Poli, G. Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Curr. Med. Chem. 17, 74\u201395 (2010).","journal-title":"Curr. Med. Chem."},{"key":"56709_CR18","doi-asserted-by":"crossref","unstructured":"Zhou, J., Xie, G. & Yan, X. Encyclopedia of Traditional Chinese Medicines-Molecular Structures, Pharmacological Activities, Natural Sources And Applications: Indexes 6 (Springer Science & Business Media, 2011).","DOI":"10.1007\/978-3-642-16744-7"},{"key":"56709_CR19","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1021\/acs.jnatprod.5b00011","volume":"78","author":"F Fonseca-Silva","year":"2015","unstructured":"Fonseca-Silva, F., Canto-Cavalheiro, M. M., Menna-Barreto, R. F. & Almeida-Amaral, E. E. Effect of apigenin on Leishmania amazonensis is associated with reactive oxygen species production followed by mitochondrial dysfunction. J. Nat. Prod. 78, 880\u2013884 (2015).","journal-title":"J. Nat. Prod."},{"key":"56709_CR20","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1039\/C9AN00948E","volume":"144","author":"MV Ara\u00fajo","year":"2019","unstructured":"Ara\u00fajo, M. V. et al. Flavonoids induce cell death in Leishmania amazonensis: in vitro characterization by flow cytometry and Raman spectroscopy. Analyst 144, 5232\u20135244 (2019).","journal-title":"Analyst"},{"key":"56709_CR21","first-page":"1","volume":"1","author":"ML Clavin","year":"2017","unstructured":"Clavin, M. L. et al. Antiprotozoal activity of flavonoids from Eupatorium arnottianum. J. Parasitic Diseases: Diagnosis Therapy. 1, 1\u20136 (2017).","journal-title":"J. Parasitic Diseases:Diagnosis Therapy"},{"key":"56709_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.exppara.2012.01.015","volume":"130","author":"E da Silva","year":"2012","unstructured":"da Silva, E., do Carmo Maquiaveli, R. & Magalh\u00e3es, C. The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase. Exp. Parasitol. 130, 183\u2013188 (2012).","journal-title":"Exp. Parasitol."},{"key":"56709_CR23","doi-asserted-by":"publisher","first-page":"e14666","DOI":"10.1371\/journal.pone.0014666","volume":"6","author":"F Fonseca-Silva","year":"2011","unstructured":"Fonseca-Silva, F. et al. Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin-induced death in Leishmania amazonensis. PLoS ONE. 6, e14666 (2011).","journal-title":"PLoS ONE"},{"key":"56709_CR24","doi-asserted-by":"publisher","first-page":"106325","DOI":"10.1016\/j.actatropica.2022.106325","volume":"228","author":"E Alemzadeh","year":"2022","unstructured":"Alemzadeh, E., Karamian, M., Abedi, F. & Hanafi-Bojd, M. Y. Topical treatment of cutaneous leishmaniasis lesions using quercetin\/Artemisia-capped silver nanoparticles ointment: modulation of inflammatory response. Acta Trop. 228, 106325 (2022).","journal-title":"Acta Trop."},{"key":"56709_CR25","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/ph17081014","volume":"17","author":"VL Lessa","year":"2024","unstructured":"Lessa, V. L. et al. In vitro evaluation of the combinatorial effect of naringenin and miltefosine against Leishmania amazonensis. Pharmaceuticals 17, 1014 (2024).","journal-title":"Pharmaceuticals"},{"key":"56709_CR26","doi-asserted-by":"publisher","first-page":"111663","DOI":"10.1016\/j.molbiopara.2024.111663","volume":"261","author":"M Karamian","year":"2025","unstructured":"Karamian, M. et al. Glucantime and quercetin electrospun nanofiber membranes: fabrication and their evaluation as dressing for cutaneous leishmaniasis. Mol. Biochem. Parasitol. 261, 111663 (2025).","journal-title":"Mol. Biochem. Parasitol."},{"key":"56709_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0003-9861(52)90164-1","volume":"37","author":"S Hattori","year":"1952","unstructured":"Hattori, S. & Matsuda, H. Rhoifolin, a new flavone glycoside, isolated from the leaves of Rhus succedanea. Arch. Biochem. Biophys. 37, 85\u201389 (1952).","journal-title":"Arch. Biochem. Biophys."},{"key":"56709_CR28","first-page":"289","volume":"24","author":"CS K\u0131l\u0131\u00e7","year":"2025","unstructured":"K\u0131l\u0131\u00e7, C. S. et al. Rhoifolin: a promising flavonoid with potent cytotoxic and anticancer properties: molecular mechanisms and therapeutic potential. EXCLI J. 24, 289\u2013320 (2025).","journal-title":"EXCLI J."},{"key":"56709_CR29","doi-asserted-by":"publisher","first-page":"e9489","DOI":"10.1590\/1414-431x20209489","volume":"53","author":"S Peng","year":"2020","unstructured":"Peng, S. et al. Rhoifolin regulates oxidative stress and proinflammatory cytokine levels in Freund\u2019s adjuvant-induced rheumatoid arthritis via inhibition of NF-\u03baB. Braz. J. Med. Biol. Res. 53, e9489 (2020).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"56709_CR30","doi-asserted-by":"publisher","first-page":"e202300117","DOI":"10.1002\/cbdv.202300117","volume":"20","author":"G Zengin","year":"2023","unstructured":"Zengin, G., Mostafa, N. M., Abdelkhalek, Y. M. & Eldahshan, O. A. Antioxidant and enzyme inhibitory activities of Rhoifolin Flavonoid: in vitro and in silico studies. Chem. Biodivers. 20, e202300117 (2023).","journal-title":"Chem. Biodivers."},{"key":"56709_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.34172\/PS.2023.23","volume":"30","author":"SM Rahimnia","year":"2023","unstructured":"Rahimnia, S. M. et al. Green preparation, characterization, wound healing assessment, and histopathological evaluation of vitamin A encapsulated in niosome and solid lipid nanoparticle. Pharm. Sci. 30, 70\u201384 (2023).","journal-title":"Pharm. Sci."},{"key":"56709_CR32","first-page":"161","volume":"14","author":"M Saeedi","year":"2023","unstructured":"Saeedi, M. et al. Green formulation of spironolactone loaded chitosan-coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial. Adv. Pharm. Bull. 14, 161 (2023).","journal-title":"Adv. Pharm. Bull."},{"key":"56709_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.34172\/PS.2022.34","volume":"29","author":"SK Morteza","year":"2023","unstructured":"Morteza, S. K. et al. Preparation and in-vitro evaluation of ketoconazole-loaded niosome (ketosome) for drug delivery to cutaneous candidiasis. Pharm. Sci. 29, 208\u2013218 (2023).","journal-title":"Pharm. Sci."},{"key":"56709_CR34","doi-asserted-by":"publisher","first-page":"e1891","DOI":"10.1002\/wnan.1891","volume":"15","author":"H Bach","year":"2023","unstructured":"Bach, H. & Lorenzo-Leal, A. C. Use of niosomes for the treatment of intracellular pathogens infecting the lungs. Wiley Interdiscipl. Rev. Nanomed. Nanobiotechnol. 15, e1891 (2023).","journal-title":"Wiley Interdiscipl. Rev. Nanomed. Nanobiotechnol."},{"key":"56709_CR35","doi-asserted-by":"crossref","unstructured":"Sangboonruang, S. et al. Potentiality of melittin-loaded niosomal vesicles against vancomycin-intermediate Staphylococcus aureus and Staphylococcal skin infection. Int. J. Nanomed. 2021, 7639\u20137661 (2021).","DOI":"10.2147\/IJN.S325901"},{"key":"56709_CR36","doi-asserted-by":"crossref","unstructured":"Bashir, S. et al. Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti-leishmanial effect. Heliyon 9, 2563 (2023).","DOI":"10.1016\/j.heliyon.2023.e21939"},{"key":"56709_CR37","doi-asserted-by":"publisher","first-page":"108942","DOI":"10.1016\/j.biopha.2019.108942","volume":"116","author":"M Mostafavi","year":"2019","unstructured":"Mostafavi, M. et al. Niosomal formulation of amphotericin B alone and in combination with glucantime: in vitro and in vivo leishmanicidal effects. Biomed. Pharmacother. 116, 108942 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"56709_CR38","doi-asserted-by":"publisher","first-page":"10073","DOI":"10.1038\/s41598-024-60883-0","volume":"14","author":"U Niroumand","year":"2024","unstructured":"Niroumand, U. et al. Preparation and characterization of artemether-loaded niosomes in Leishmania major-induced cutaneous leishmaniasis. Sci. Rep. 14, 10073 (2024).","journal-title":"Sci. Rep."},{"key":"56709_CR39","doi-asserted-by":"publisher","first-page":"2173335","DOI":"10.1080\/10717544.2023.2173335","volume":"30","author":"A Anjum","year":"2023","unstructured":"Anjum, A. et al. Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis. Drug Deliv. 30, 2173335 (2023).","journal-title":"Drug Deliv."},{"key":"56709_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/pharmaceutics13040451","volume":"13","author":"B Szulc-Musio\u0142","year":"2021","unstructured":"Szulc-Musio\u0142, B. & Sarecka-Hujar, B. The use of micro-and nanocarriers for resveratrol delivery into and across the skin in different skin diseases\u2014a literature review. Pharmaceutics 13, 451 (2021).","journal-title":"Pharmaceutics"},{"key":"56709_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12896-024-00874-1","volume":"24","author":"J Hemmati","year":"2024","unstructured":"Hemmati, J. et al. Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections. BMC Biotechnol. 24, 47 (2024).","journal-title":"BMC Biotechnol."},{"key":"56709_CR42","doi-asserted-by":"crossref","unstructured":"Hu, L. & Luo, Y. Botanical flavonoids efficacy, absorption, metabolism and advanced pharmaceutical technology for improving bioavailability. Molecules 30, 1184 (2025).","DOI":"10.3390\/molecules30051184"},{"key":"56709_CR43","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/01932691.2020.1842211","volume":"43","author":"M Saeedi","year":"2022","unstructured":"Saeedi, M. et al. Controlling atorvastatin release from liquisolid systems. J. Dispers. Sci. Technol. 43, 375\u2013384 (2022).","journal-title":"J. Dispers. Sci. Technol."},{"key":"56709_CR44","doi-asserted-by":"crossref","unstructured":"Sharifi, F. et al. In silico and in vitro cytotoxic effects of amphotericin B and its niosomal form on human umbilical vein endothelial cells: exploration of apoptosis-related pathways. Gene Rep. 2026, 102429 (2026).","DOI":"10.1016\/j.genrep.2026.102429"},{"key":"56709_CR45","first-page":"892","volume":"14","author":"A Etemadifar","year":"2024","unstructured":"Etemadifar, A. et al. Preparation, characterization, and leishmanicidal assessment of silver-and dapsone-loaded niosomes co-administration: in silico and in vitro study. Adv. Pharm. Bull. 14, 892 (2024).","journal-title":"Adv. Pharm. Bull."},{"key":"56709_CR46","doi-asserted-by":"publisher","first-page":"104156","DOI":"10.1016\/j.arabjc.2022.104156","volume":"15","author":"S Bahraminejad","year":"2022","unstructured":"Bahraminejad, S. et al. Preparation and evaluation of physicochemical properties and anti-leishmanial activity of zirconium\/tioxolone niosomes against Leishmania major. Arab. J. Chem. 15, 104156 (2022).","journal-title":"Arab. J. Chem."},{"key":"56709_CR47","doi-asserted-by":"crossref","unstructured":"Sangboonruang, S. & Semakul, N. Potentiality of melittin-loaded niosomal vesicles against vancomycin-intermediate Staphylococcus aureus and Staphylococcal skin infection. Int. J. Nanomed. 2021, 7639\u20137661 (2021).","DOI":"10.2147\/IJN.S325901"},{"key":"56709_CR48","doi-asserted-by":"publisher","first-page":"106206","DOI":"10.1016\/j.envint.2020.106206","volume":"146","author":"O Martin","year":"2021","unstructured":"Martin, O. et al. Ten years of research on synergisms and antagonisms in chemical mixtures: a systematic review and quantitative reappraisal of mixture studies. Environ. Int. 146, 106206 (2021).","journal-title":"Environ. Int."},{"key":"56709_CR49","doi-asserted-by":"crossref","unstructured":"Barani, M. et al. Niosome as an effective nanoscale solution for the treatment of microbial infections. BioMed Res. Int. 2023, 9933283 (2023).","DOI":"10.1155\/2023\/9933283"},{"key":"56709_CR50","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3390\/ijms19061801","volume":"19","author":"C Atri","year":"2018","unstructured":"Atri, C., Guerfali, F. Z. & Laouini, D. Role of human macrophage polarization in inflammation during infectious diseases. Int. J. Mol. Sci. 19, 1801 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"56709_CR51","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1016\/j.immuni.2021.09.021","volume":"54","author":"P Formaglio","year":"2021","unstructured":"Formaglio, P. et al. Nitric oxide controls proliferation of Leishmania major by inhibiting the recruitment of permissive host cells. Immunity 54, 2724\u20132739 (2021).","journal-title":"Immunity"},{"key":"56709_CR52","first-page":"258","volume":"226","author":"N Wanasen","year":"2008","unstructured":"Wanasen, N. & Soong, L. L-arginine metabolism and its impact on host immunity to Leishmania infection. Immunol. Rev. 226, 258\u2013270 (2008).","journal-title":"Immunol. Rev."},{"key":"56709_CR53","doi-asserted-by":"crossref","unstructured":"Zanatta, J. M., Acu\u00f1a, S. M., Bento, C. A., Stolf, B. S. & Muxel, S. M. Polyamines shift expression of macrophage L-arginine metabolism related-genes during Leishmania amazonensis infection. bioRxiv (2022).","DOI":"10.1101\/2022.05.27.493766"},{"key":"56709_CR54","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.foodchem.2013.05.025","volume":"141","author":"L Manjolin","year":"2013","unstructured":"Manjolin, L. et al. Dietary flavonoids fisetin, luteolin and their derived compounds inhibit arginase, a central enzyme in Leishmania (Leishmania) amazonensis infection. Food Chem. 141, 2253\u20132262 (2013).","journal-title":"Food Chem."},{"key":"56709_CR55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.mib.2021.07.012","volume":"63","author":"C Ferreira","year":"2021","unstructured":"Ferreira, C., Estaquier, J. & Silvestre, R. Immune-metabolic interactions between Leishmania and macrophage host. Curr. Opin. Microbiol. 63, 231\u2013237 (2021).","journal-title":"Curr. Opin. Microbiol."},{"key":"56709_CR56","doi-asserted-by":"publisher","first-page":"e0012735","DOI":"10.1371\/journal.pntd.0012735","volume":"19","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Progress in antileishmanial drugs: mechanisms, challenges, and prospects. PLoS Negl. Trop. Dis. 19, e0012735 (2025).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"56709_CR57","doi-asserted-by":"crossref","unstructured":"Kaushal, R. S., Kaushik, A. & Prabha, C. R. The Role of Reactive Oxygen Species in Human Health and Diseas 269\u2013310 (IGI Global Scientific Publishing, 2025).","DOI":"10.4018\/979-8-3693-7919-6.ch008"},{"key":"56709_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13071-016-1472-y","volume":"9","author":"EH Roma","year":"2016","unstructured":"Roma, E. H. et al. Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection. Parasites vectors. 9, 193 (2016).","journal-title":"Parasites vectors"},{"key":"56709_CR59","doi-asserted-by":"crossref","unstructured":"Basmaciyan, L. & Casanova, M. Cell death in Leishmania. Parasite 26, 71 (2019).","DOI":"10.1051\/parasite\/2019071"},{"key":"56709_CR60","doi-asserted-by":"publisher","first-page":"1059168","DOI":"10.3389\/fcimb.2022.1059168","volume":"12","author":"RF Santos","year":"2023","unstructured":"Santos, R. F. et al. Therapeutic effect of oral quercetin in hamsters infected with Leishmania Viannia braziliensis. Front. Cell. Infect. Microbiol. 12, 1059168 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"56709_CR61","first-page":"521","volume":"14","author":"M Saduqi","year":"2019","unstructured":"Saduqi, M. et al. Anti-leishmanial and immunomodulatory effects of epigallocatechin 3-o-gallate on leishmania tropica: Apoptosis and gene expression profiling. Iran. J. Parasitol. 14, 521 (2019).","journal-title":"Iran. J. Parasitol."},{"key":"56709_CR62","doi-asserted-by":"crossref","unstructured":"Fonseca-Silva, F., Inacio, J. D., Canto-Cavalheiro, M. M. & Almeida-Amaral, E. E. Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes. J. Nat. Prod. 76, 1505\u20131508 (2013).","DOI":"10.1021\/np400193m"},{"key":"56709_CR63","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/genes14040778","volume":"14","author":"C Valli\u00e8res","year":"2023","unstructured":"Valli\u00e8res, C. et al. Redox-based strategies against infections by eukaryotic pathogens. Genes 14, 778 (2023).","journal-title":"Genes"},{"key":"56709_CR64","doi-asserted-by":"publisher","first-page":"108942","DOI":"10.1016\/j.biopha.2019.108942","volume":"116","author":"M Mostafavi","year":"2019","unstructured":"Mostafavi, M. Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects. Biomed. Pharmacother. 116, 108942 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"56709_CR65","doi-asserted-by":"publisher","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","volume":"104","author":"BM Roatt","year":"2020","unstructured":"Roatt, B. M. et al. Recent advances and new strategies on leishmaniasis treatment. Appl. Microbiol. Biotechnol. 104, 8965\u20138977 (2020).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"56709_CR66","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/ph17081014","volume":"17","author":"VL Lessa","year":"2024","unstructured":"Lessa, V. L. & Gon\u00e7alves, G. In vitro evaluation of the combinatorial effect of naringenin and miltefosine against Leishmania amazonensis. Pharmaceuticals 17, 1014 (2024).","journal-title":"Pharmaceuticals"},{"key":"56709_CR67","doi-asserted-by":"publisher","first-page":"427","DOI":"10.19113\/sdufenbed.1074029","volume":"26","author":"FK \u00c7etin","year":"2022","unstructured":"\u00c7etin, F. K. & Ate\u015f, S. C. In vitro investigation of Rutin-loaded PLGA nanoparticles on leishmania infantum promastigotes. S\u00fcleyman Demirel \u00dcniversitesi Fen Bilimleri Enstit\u00fcs\u00fc Dergisi. 26, 427\u2013434 (2022).","journal-title":"S\u00fcleyman Demirel \u00dcniversitesi Fen Bilimleri Enstit\u00fcs\u00fc Dergisi"},{"key":"56709_CR68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/2221-1691.367689","volume":"13","author":"A Oryan","year":"2023","unstructured":"Oryan, A., Bemani, E. & Bahrami, S. Anti-leishmanial, immunomodulatory and anti-oxidative activity of quercetin against cutaneous leishmaniasis caused by Leishmania major. Asian Pac. J. Trop. Biomed. 13, 26\u201334 (2023).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"56709_CR69","doi-asserted-by":"publisher","first-page":"e3093","DOI":"10.1371\/journal.pntd.0003093","volume":"8","author":"JD Inacio","year":"2014","unstructured":"Inacio, J. D., Gervazoni, L., Canto-Cavalheiro, M. M. & Almeida-Amaral, E. E. The effect of (-)-epigallocatechin 3-O-gallate in vitro and in vivo in Leishmania braziliensis: involvement of reactive oxygen species as a mechanism of action. PLoS Negl. Trop. Dis. 8, e3093 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"56709_CR70","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/metabo13020285","volume":"13","author":"YN Fr\u00f3es","year":"2023","unstructured":"Fr\u00f3es, Y. N. et al. Chemical characterization and leishmanicidal activity in vitro and in silico of natural products obtained from leaves of Vernonanthura brasiliana (L.) H. Rob (Asteraceae). Metabolites 13, 285 (2023).","journal-title":"Metabolites"},{"key":"56709_CR71","doi-asserted-by":"publisher","first-page":"703985","DOI":"10.3389\/fphar.2021.703985","volume":"12","author":"JV Silva-Silva","year":"2021","unstructured":"Silva-Silva, J. V. et al. Antileishmanial activity of flavones-rich fraction from Arrabidaea chica Verlot (Bignoniaceae). Front. Pharmacol. 12, 703985 (2021).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56709-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56709-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56709-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:02:14Z","timestamp":1787018534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56709-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56709"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56709-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The present study was approved by the Research Ethics Committees of Biosafety & Laboratory, Zanjan University of Medical Sciences, Zanjan, Iran (Approval ID. IR.ZUMS.BLC.1402.042).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"25854"}}